HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/29102 |
Resumo: | 2019-04-30 |
id |
CRUZ_147b7cf76e00c26d9ecec94a4a688cef |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/29102 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Palumbo, Philip J.Fogel, Jessica M.Hudelson, Sarah E.Wilson, Ethan A.Hart, StephenHovind, LauraPiwowar-Manning, EstelleWallis, CarolePapathanasopoulos, Maria A.Morgado, Mariza G.Saravanan, ShanmugamTripathy, SrikanthEron, Joseph J.Gallant, Joel E.McCauley, MarybethGamble, TheresaHosseinipour, Mina C.Kumarasamy, NagalingeswaranHakim, James G.Pilotto, Jose H.Kumwenda, JohnstoneAkelo, VictorGodbole, Sheela V.Santos, Breno R.Grinsztejn, BeatrizPanchia, RavindreChariyalertsak, SuwatMakhema, JosephBadal-Faesen, SharlaaChen, Ying Q.Cohen, Myron S.Eshleman, Susan H.2018-09-27T14:48:42Z2018-09-27T14:48:42Z2018PALUMBO, P. J. et al. HIV drug resistance in adults receiving early versus delayed antirretroviral therapy: HPTN 052. JAIDS, v. 77, n. 5, p. 484-491, 2018.1525-4135https://www.arca.fiocruz.br/handle/icict/2910210.1097/QAI.0000000000001623engHIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article2019-04-30Department of Pathology. Johns Hopkins University School of Medicine. Baltimore, USA.Department of Pathology. Johns Hopkins University School of Medicine. Baltimore, USA.Department of Pathology. Johns Hopkins University School of Medicine. Baltimore, USA.Vaccine and Infectious Disease Division. Fred Hutchinson Cancer Research Center. Seattle, USA.Frontier Science and Technology Research Foundation. Amherst. NY, USA.Frontier Science and Technology Research Foundation. Amherst, NY, USA.Department of Pathology. Johns Hopkins University School of Medicine. Baltimore, USA.Specialty Molecular Division, Lancet Laboratories and BARC-SA. Johannesburg, South Africa.HIV Pathogenesis Research Unit. Faculty of Health Sciences. University of the Witwatersrand. Johannesburg, South Africa.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratorio de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.Y. R. Gaitonde Centre for AIDS Research and Education, Chennai, India.National Institute for Research in Tuberculosis, Chennai, India.Department of Medicine. University of North Carolina at Chapel Hill. Chapel Hill, USA.Department of Specialty Services. Southwest CARE Center. Santa Fe, USA.HPTN Leadership and Operations Center. Washington, DC, USA.HPTN Leadership and Operations Center. Durham, USA.Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill/ UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, MalawiCART CRS, YRGCARE Medical Centre. VHS. Chennai, India.Department of Medicine. University of Zimbabwe. Harare, Zimbabwe.Hospital Geral de Nova Iguacu. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratorio de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.College of Medicine-Johns Hopkins Project. Blantyre, Malawi.Kenya Medical Research Institute (KEMRI)-Centers for Disease Control (CDC), Kisumu, Kenya.Department of Epidemiology and Biostatistics. National AIDS Research Institute (ICMR). Pune, India.Department of Infectious Diseases. Hospital Nossa Senhora da Conceição. Porto Alegre, RS, Brazil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.Perinatal HIV Research Unit. University of the Witwatersrand. Soweto HPTN CRS. Soweto, South Africa.Research Institute for Health Sciences. Chiang Mai University. Chiang Mai, Thailand.Botswana-Harvard AIDS Institute Partnership. Gaborone, Botswana.Clinical HIV Research Unit. Department of Internal Medicine. School of Clinical Medicine. Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.Vaccine and Infectious Disease Division. Fred Hutchinson Cancer Research Center. Seattle, WA.Department of Medicine. University of North Carolina at Chapel Hill. Chapel Hill, USA.Department of Pathology. Johns Hopkins University School of Medicine. Baltimore, USA.We evaluated HIV drug resistance in adults who received early vs. delayed antiretroviral therapy (ART) in a multinational trial [HIV Prevention Trials Network (HPTN) 052, enrollment 2005-2010]. In HPTN 052, 1763 index participants were randomized to start ART at a CD4 cell count of 350-550 cells/mm (early ART arm) or <250 cells/mm (delayed ART arm). In May 2011, interim study results showed benefit of early ART, and all participants were offered ART regardless of CD4 cell count; the study ended in 2015.HIVHPTN 052Early ARTVirologic failureResistanceNãoNão Publicadoinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83099https://www.arca.fiocruz.br/bitstream/icict/29102/1/license.txt586c046dcfeef936e32f0323bb9a47c0MD51ORIGINALHIV drug resistance in adults receiving early_Beatriz_Grinsztejn_INI_Lapclin-AIDS_2018.pdfHIV drug resistance in adults receiving early_Beatriz_Grinsztejn_INI_Lapclin-AIDS_2018.pdfapplication/pdf926904https://www.arca.fiocruz.br/bitstream/icict/29102/2/HIV%20drug%20resistance%20in%20adults%20receiving%20early_Beatriz_Grinsztejn_INI_Lapclin-AIDS_2018.pdf7f69b3791d8501b3fcc41a76de9d924dMD52TEXTHIV drug resistance in adults receiving early_Beatriz_Grinsztejn_INI_Lapclin-AIDS_2018.pdf.txtHIV drug resistance in adults receiving early_Beatriz_Grinsztejn_INI_Lapclin-AIDS_2018.pdf.txtExtracted texttext/plain51606https://www.arca.fiocruz.br/bitstream/icict/29102/3/HIV%20drug%20resistance%20in%20adults%20receiving%20early_Beatriz_Grinsztejn_INI_Lapclin-AIDS_2018.pdf.txt81209afc5a9f1af1c25fde7e4a6752deMD53icict/291022021-03-24 16:32:23.664oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-03-24T19:32:23Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052 |
title |
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052 |
spellingShingle |
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052 Palumbo, Philip J. HIV HPTN 052 Early ART Virologic failure Resistance |
title_short |
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052 |
title_full |
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052 |
title_fullStr |
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052 |
title_full_unstemmed |
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052 |
title_sort |
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052 |
author |
Palumbo, Philip J. |
author_facet |
Palumbo, Philip J. Fogel, Jessica M. Hudelson, Sarah E. Wilson, Ethan A. Hart, Stephen Hovind, Laura Piwowar-Manning, Estelle Wallis, Carole Papathanasopoulos, Maria A. Morgado, Mariza G. Saravanan, Shanmugam Tripathy, Srikanth Eron, Joseph J. Gallant, Joel E. McCauley, Marybeth Gamble, Theresa Hosseinipour, Mina C. Kumarasamy, Nagalingeswaran Hakim, James G. Pilotto, Jose H. Kumwenda, Johnstone Akelo, Victor Godbole, Sheela V. Santos, Breno R. Grinsztejn, Beatriz Panchia, Ravindre Chariyalertsak, Suwat Makhema, Joseph Badal-Faesen, Sharlaa Chen, Ying Q. Cohen, Myron S. Eshleman, Susan H. |
author_role |
author |
author2 |
Fogel, Jessica M. Hudelson, Sarah E. Wilson, Ethan A. Hart, Stephen Hovind, Laura Piwowar-Manning, Estelle Wallis, Carole Papathanasopoulos, Maria A. Morgado, Mariza G. Saravanan, Shanmugam Tripathy, Srikanth Eron, Joseph J. Gallant, Joel E. McCauley, Marybeth Gamble, Theresa Hosseinipour, Mina C. Kumarasamy, Nagalingeswaran Hakim, James G. Pilotto, Jose H. Kumwenda, Johnstone Akelo, Victor Godbole, Sheela V. Santos, Breno R. Grinsztejn, Beatriz Panchia, Ravindre Chariyalertsak, Suwat Makhema, Joseph Badal-Faesen, Sharlaa Chen, Ying Q. Cohen, Myron S. Eshleman, Susan H. |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Palumbo, Philip J. Fogel, Jessica M. Hudelson, Sarah E. Wilson, Ethan A. Hart, Stephen Hovind, Laura Piwowar-Manning, Estelle Wallis, Carole Papathanasopoulos, Maria A. Morgado, Mariza G. Saravanan, Shanmugam Tripathy, Srikanth Eron, Joseph J. Gallant, Joel E. McCauley, Marybeth Gamble, Theresa Hosseinipour, Mina C. Kumarasamy, Nagalingeswaran Hakim, James G. Pilotto, Jose H. Kumwenda, Johnstone Akelo, Victor Godbole, Sheela V. Santos, Breno R. Grinsztejn, Beatriz Panchia, Ravindre Chariyalertsak, Suwat Makhema, Joseph Badal-Faesen, Sharlaa Chen, Ying Q. Cohen, Myron S. Eshleman, Susan H. |
dc.subject.en.pt_BR.fl_str_mv |
HIV HPTN 052 Early ART Virologic failure Resistance |
topic |
HIV HPTN 052 Early ART Virologic failure Resistance |
description |
2019-04-30 |
publishDate |
2018 |
dc.date.accessioned.fl_str_mv |
2018-09-27T14:48:42Z |
dc.date.available.fl_str_mv |
2018-09-27T14:48:42Z |
dc.date.issued.fl_str_mv |
2018 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
PALUMBO, P. J. et al. HIV drug resistance in adults receiving early versus delayed antirretroviral therapy: HPTN 052. JAIDS, v. 77, n. 5, p. 484-491, 2018. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/29102 |
dc.identifier.issn.pt_BR.fl_str_mv |
1525-4135 |
dc.identifier.doi.none.fl_str_mv |
10.1097/QAI.0000000000001623 |
identifier_str_mv |
PALUMBO, P. J. et al. HIV drug resistance in adults receiving early versus delayed antirretroviral therapy: HPTN 052. JAIDS, v. 77, n. 5, p. 484-491, 2018. 1525-4135 10.1097/QAI.0000000000001623 |
url |
https://www.arca.fiocruz.br/handle/icict/29102 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/29102/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/29102/2/HIV%20drug%20resistance%20in%20adults%20receiving%20early_Beatriz_Grinsztejn_INI_Lapclin-AIDS_2018.pdf https://www.arca.fiocruz.br/bitstream/icict/29102/3/HIV%20drug%20resistance%20in%20adults%20receiving%20early_Beatriz_Grinsztejn_INI_Lapclin-AIDS_2018.pdf.txt |
bitstream.checksum.fl_str_mv |
586c046dcfeef936e32f0323bb9a47c0 7f69b3791d8501b3fcc41a76de9d924d 81209afc5a9f1af1c25fde7e4a6752de |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009060969054208 |